Lack of association between HLA and asymptomatic SARS-CoV-2 infection
Marchal, A.; Cirulli, E. T.; Neveux, I.; Bellos, E.; Thwaites, R. S.; Schiabor Barrett, K. M.; Zhang, Y.; Nemes-Bokun, I.; Kalinova, M.; Catchpole, A.; Tangye, S. G.; Spaan, A. N.; Lack, J. B.; Ghosn, J.; Burdet, C.; Gorochov, G.; Tubach, F.; Hausfater, P.; COVID Human Genetic Effort, ; COVIDeF Study Group, ; French COVID Cohort Study Group, ; CoV-Contact Cohort, ; COVID-STORM Clinicians, ; COVID Clinicians, ; Orchestra Working Group, ; Amsterdam UMC Covid-19 Biobank, ; NIAID-USUHS COVID Study Group, ; Dalgard, C. L.; Zhang, S.-Y.; Zhang, Q.; Chiu, C.; Fellay, J.; Grzymski, J. J.; San
Show abstract
Human genetic studies of critical COVID-19 pneumonia have revealed the essential role of type I interferon-dependent innate immunity to SARS-CoV-2 infection. Conversely, an association between the HLA-B*15:01 allele and asymptomatic SARS-CoV-2 infection in unvaccinated individuals was recently reported, suggesting a contribution of pre-existing T cell-dependent adaptive immunity. We report a lack of association of classical HLA alleles, including HLA-B*15:01, with pre-omicron asymptomatic SARS-CoV-2 infection in unvaccinated participants in a prospective population-based study in the US (191 asymptomatic vs. 945 symptomatic COVID-19 cases). Moreover, we found no such association in the international COVID Human Genetic Effort cohort (206 asymptomatic vs. 574 mild or moderate COVID-19 cases and 1,625 severe or critical COVID-19 cases). Finally, in the Human Challenge Characterisation study, the three HLA-B*15:01 individuals infected with SARS-CoV-2 developed symptoms. As with other acute primary infections, no classical HLA alleles favoring an asymptomatic course of SARS-CoV-2 infection were identified. These findings suggest that memory T-cell immunity to seasonal coronaviruses does not strongly influence the outcome of SARS-CoV-2 infection in unvaccinated individuals.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19 96%
- A Neanderthal OAS1 isoform Protects Against COVID-19 Susceptibility and Severity: Results from Mendelian Randomization and Case-Control Studies 96%
- Genetic association analysis of 269 rare diseases reveals novel aetiologies 94%
Similar papers in this journal
- Failure to replicate the association of rare loss-of-function variants in type I IFN immunity genes with severe COVID-19 97%
- Macrophage depletion blocks congenital SARM1-dependent neuropathy 92%
- Targeting Specific Kinase Substrates Rescues Increased Colitis Severity Induced by the Crohn's Disease-Linked LRRK2-N2081D Variant 91%
Similar papers in this journal
- Antibody therapy reverses biological signatures of COVID-19 progression 94%
- Non-severe SARS-CoV-2 infection is characterised by very early T cell proliferation independent of type 1 interferon responses and distinct from other acute respiratory viruses 94%
- Rewired type I IFN signaling is linked to age-dependent differences in COVID-19 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.